Abstract
Background and Hypothesis Voice atypicalities are potential markers of clinical features of schizophrenia (e.g., negative symptoms). A recent meta-analysis identified an acoustic profile associated with schizophrenia (reduced pitch variability and increased pauses), but also highlighted shortcomings in the field: small sample sizes, little attention to the heterogeneity of the disorder, and to generalizing findings to diverse samples and languages.
Study Design We provide a critical cumulative approach to vocal atypicalities in schizophrenia, where we conceptually and statistically build on previous studies. We aim at identifying a cross-linguistically reliable acoustic profile of schizophrenia and assessing sources of heterogeneity (symptomatology, pharmacotherapy, clinical and social characteristics). We relied on previous meta-analysis to build and analyze a large cross-linguistic dataset of audio recordings of 231 patients with schizophrenia and 238 matched controls (>4.000 recordings in Danish, German, Mandarin and Japanese). We used multilevel Bayesian modeling, contrasting meta-analytically informed and skeptical inferences.
Study Results We found only a minimal generalizable acoustic profile of schizophrenia (reduced pitch variability), while duration atypicalities replicated only in some languages. We identified reliable associations between acoustic profile and individual differences in clinical ratings of negative symptoms, medication, age and gender. However, these associations vary across languages.
Conclusions The findings indicate that a strong cross-linguistically reliable acoustic profile of schizophrenia is unlikely. Rather, if we are to devise effective clinical applications able to target different ranges of patients, we need first to establish larger and more diverse cross-linguistic datasets, focus on individual differences, and build self-critical cumulative approaches.
Competing Interest Statement
Riccardo Fusaroli has been a paid consultant on related but not overlapping topics for Roche. The other authors have no real or potential conflicts of interest that could have influenced the research.
Funding Statement
A.P is supported by a Marie Skłodowska-Curie Actions H2020-MSCA-IF-2018 grant (ID: 832518, Project: MOVES). A.S is supported by the Carlsberg Foundation. K. K has been supported by Japan Society for the promotion of Science (JSPS) (PE 07550).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
- The study was approved by The Central Denmark Region Committees on Biomedical Research Ethics and the Danish Data Protection Agency - The study was approved by the Ethics Committee of the University of Muenster and the State Chamber of Physicians of Nordrhein-Westphalia - The project was approved by the Ethics committee of Renmin Hospital of Wuhan University and the Institutional Review Board of the Institute of Psychology, the Chinese Academy of Sciences
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
- More detailed description of the recording settings and experimental procedure for the different samples in our corpus. - More details about the sample size of the present study and why the sample size is appropriate compared to the previous literature and for the aim of the present study. - More detail on how the variability between the different samples of our corpus is both a strength and a limitation of the present study.
Data Availability
The original speech recordings cannot be shared as they are considered identifiable data, in line with our consent forms and current data privacy regulations.